Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature

Background. Biologic therapy to inhibit tumor necrosis factor-alpha (TNF-α) is an effective, safe treatment for patients with inflammatory bowel disease (IBD). All TNF-α inhibitors have been associated with liver toxicity, but many of these cases have been reported in patients receiving therapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Parekh, Ravish, Kaur, Nirmal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966260/
https://www.ncbi.nlm.nih.gov/pubmed/24707412
http://dx.doi.org/10.1155/2014/956463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966260/
https://www.ncbi.nlm.nih.gov/pubmed/24707412
http://dx.doi.org/10.1155/2014/956463

Ejemplares similares